Clinical trials recruiting for Microsatellite Instability-High Colorectal Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Bevacizumab | 2 |
| Nivolumab | 2 |
| Carboplatin | 1 |
| FOG-001 | 1 |
| FOLFIRI Protocol | 1 |
| Ipilimumab | 1 |
| NEO212 Oral Capsule | 1 |
| Paclitaxel | 1 |
| Pembrolizumab | 1 |
| Regorafenib | 1 |
| Trifluridine/tipiracil | 1 |
| mFOLFOX-6 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Florida | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Arizona | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Related conditions
Trials recruiting for Microsatellite Instability-High Colorectal Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Microsatellite Instability-High Colorectal Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.